Factors affecting outcomes after supermicrosurgical lymphovenous anastomosis in a defined patient population

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017413

Enrollment

Registered

2019-06-25

Start date

2015-02-25

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I89.0

Interventions

Group 1: Patients who received lymphovenous anastomoses for an existing therapy-resistant lymphedema after exhausting conservative therapy measures.

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All adult patients who are able and willing to consent and who have received lymphovenous anastomoses for an existing lymphedema after exhaustion of the conservative therapy measures.

Exclusion criteria

Exclusion criteria: Patients with liver dysfunction, known allergy to indocyanine green, sodium iodide, iodine, hyperthyroidism, focal and diffuse thyroid autonomy, pregnancy and lactation.

Design outcomes

Primary

Measure	Time frame
The aim of this study is to determine the short- and long-term results as well as the most important factors after lymphovenous anastomosis by analyzing all relevant pre-, intra- and postoperative factors in a defined patient population until the end of follow-up on 15.09.2018. Other primary endpoints was a surgical revision or death.	—

Secondary

Measure	Time frame
Extreme worsening of symptoms and increase in lymphedema	—

Countries

Germany

Contacts

Public ContactEric Klingelhöfer

Klinik für Unfallchirurgie, Orthopädie und Plastische Chirurgie Universitätsmedizin Göttingen Georg-August-Universität

Eric.Klingelhoefer@bgu-murnau.de00491737430818

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026